Naruto, Kensuke
Kawaoka, Tomokazu
Kodama, Kenichiro
Ogawa, Yutaro
Amioka, Kei
Yoshikawa, Yuki
Kikukawa, Chihiro
Suehiro, Yousuke
Yamaoka, Kenji
Ando, Yuwa
Kosaka, Yumi
Uchikawa, Shinsuke
Nakahara, Takashi
Murakami, Eisuke
Ono, Atsushi
Uchida, Takuro
Yamauchi, Masami
Okamoto, Wataru
Takahashi, Shoichi
Imamura, Michio
Chosa, Keigo
Awai, Kazuo
Kubo, Katsumaro
Nagata, Yasushi
Chayama, Kazuaki
Aikata, Hiroshi
Article History
Received: 6 December 2021
Accepted: 24 May 2022
First Online: 2 June 2022
Declarations
:
: This study was approved by the Institutional Review Board of Hiroshima University Hospital, and was based on the ethical principles of the Declaration of Helsinki 7th version in 2013 (project identification code number: E-968). Detailed written informed consent was obtained from each patient for each treatment.
: Not applicable.
: Michio Imamura has received honoraria from Bristol‐Myers Squibb and research funding from Bristol‐Myers Squibb. Kazuaki Chayama has received honoraria from MSD K.K., Bristol-Myers Squibb, Gilead Sciences and AbbVie; and research funding from Dainippon Sumitomo Pharma, TORAY, Eisai, Otsuka Pharma, Mitsubishi Tanabe Pharma, Daiichi Sankyo and Bristol-Myers Squibb; and has received research funding from Janssen, Mitsubishi Tanabe, Dainippon Sumitomo, and TORAY. Hiroshi Aikata has received honoraria from Eisai and Bayer. Other authors don’t have competing interests.